HealthDay - THURSDAY, Jan. 26 (HealthDay News) -- A new industry-funded study suggests that a molecular test can provide insight into whether patients are at high risk of a relapse after surgical treatment for a form of lung cancer.

HealthDay - THURSDAY, Jan. 26 (HealthDay News) -- Popular cholesterol-lowering statins may also lower risk for liver cancer among people with hepatitis B, a new study shows. Hepatitis B, an inflammation of the liver due to the hepatitis B virus, is one of the main causes of liver cancer.

HealthDay - (HealthDay News) -- Pain is a virtual certainty during childbirth, but there are ways to ease the discomfort without medication.

HealthDay - FRIDAY, Jan. 27 (HealthDay News) -- When a couple is trying to have a baby and can't, it can be emotionally and financially draining. But help may be available in an unexpected form: acupuncture.

HealthDay - FRIDAY, Jan. 27 (HealthDay News) -- Positive reinforcement, such as receiving small, unexpected gifts and introducing upbeat thoughts into daily routines, seems to help patients with high blood pressure take their medication as directed, according to a new study of black Americans.

HealthDay - FRIDAY, Jan. 27 (HealthDay News) -- Following the U.S. Food Drug Administration's approval last year of an intravenous formulation of acetaminophen for fever and pain in a hospital setting, researchers warn that use of the preparation could lead to serious overdoses, particularly among the youngest patients.

HealthDay - FRIDAY, Jan. 27 (HealthDay News) -- Inlyta (axitinib) has been approved by the U.S. Food and Drug Administration to treat advanced renal cell carcinoma in people who haven't responded to another drug.

HealthDay - FRIDAY, Jan. 27 (HealthDay News) -- Bydureon (exenatide extended release), Amylin Pharmaceuticals' long-acting version of the diabetes drug Byetta, has been approved by the U.S. Food and Drug Administration.